Physician profile
James S Forage
NPI 1699732917
$60,632.27
in general payments reported to CMS, 2019-2025
28 companies · $2,645 in 2025
The $2,645 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,656 · 2020: $4,758 · 2021: $13K · 2022: $14K · 2023: $14K · 2024: $4,365 · 2025: $2,645.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Consulting Fee: $5,500 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,000 · Travel and Lodging: $13.33.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,409.50 |
| Consulting Fee | $5,500.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,000.00 |
| Travel and Lodging | $13.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $15,490.31 | 2019-2025 | Proclaim, Penta, Infinity |
| Precision Spine, INC. | $13,242.55 | 2020-2025 | |
| Providence Medical Technology, INC. | $11,883.78 | 2021-2025 | |
| Medtronic USA, INC. | $5,286.07 | 2019-2020 | |
| Medtronic, INC. | $4,265.60 | 2019-2025 | Percept PC Brainsense, Aquamantys(Tm), Midas Rex |
| Boston Scientific Corporation | $3,417.94 | 2019-2025 | Vercise, General - Dbs, General - Pain Management |
| Nevro Corp. | $1,968.38 | 2020-2023 | Senza |
| Integrity Implants INC. | $1,212.61 | 2020-2022 | |
| Kls-Martin L.P. | $594.02 | 2022-2025 | |
| Biotronik Nro, INC. | $409.04 | 2023-2024 | Biotronik, Prospera |
| Depuy Synthes Sales INC. | $389.14 | 2021-2023 | Viper, Expedium Verse |
| Kuros Biosciences USA, INC | $331.15 | 2020 | |
| Stryker Corporation | $324.73 | 2019-2025 | Universal Neuro 3, Hydroset |
| Sanara Medtech INC. | $284.17 | 2024 | Celleraterx |
| Ossdsign USA Incorporated | $278.17 | 2023 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $198.74 | 2019-2021 | |
| Integra Lifesciences Corporation | $180.09 | 2019 | |
| Seaspine Orthopedics Corporation | $159.39 | 2021 | |
| Globus Medical, INC. | $148.57 | 2019 | |
| Titan Spine, LLC | $124.24 | 2019 | |
| Monteris Medical Corporation | $118.51 | 2019 | |
| Zimmer Biomet Holdings, INC. | $115.41 | 2020-2021 | |
| Orthofix Medical, INC. | $113.40 | 2023 | Spinal-Stim, Spinal-Stim |
| Arbor Pharmaceuticals, INC. | $28.27 | 2019 | |
| Penumbra, INC. | $22.34 | 2019 | |
| Genzyme Corporation | $17.66 | 2025 | |
| Olympus America INC. | $15.99 | 2019 | |
| Ethicon US, LLC | $12.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Forage listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.